76 related articles for article (PubMed ID: 12951170)
1. An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers.
Yousef GM; Diamandis EP
Clin Biochem; 2003 Sep; 36(6):443-52. PubMed ID: 12951170
[TBL] [Abstract][Full Text] [Related]
2. Crystallization and preliminary crystallographic studies of human kallikrein 7, a serine protease of the multigene kallikrein family.
Fernández IS; Ständker L; Forssmann WG; Giménez-Gallego G; Romero A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Aug; 63(Pt 8):669-72. PubMed ID: 17671364
[TBL] [Abstract][Full Text] [Related]
3. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation.
Kato K; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Uemura M; Asaoka T; Shimizu J; Doki Y; Eguchi H
Cancer Sci; 2024 May; 115(5):1520-1535. PubMed ID: 38475666
[TBL] [Abstract][Full Text] [Related]
4. The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review.
Zhang X; Jiang P; Wang C
Front Oncol; 2023; 13():1127637. PubMed ID: 37746292
[TBL] [Abstract][Full Text] [Related]
5. Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers.
Sananes A; Cohen I; Allon I; Ben-David O; Abu Shareb R; Yegodayev KM; Stepensky D; Elkabets M; Papo N
Mol Oncol; 2023 Nov; 17(11):2337-2355. PubMed ID: 37609678
[TBL] [Abstract][Full Text] [Related]
6. Stable flow-induced expression of KLK10 inhibits endothelial inflammation and atherosclerosis.
Williams D; Mahmoud M; Liu R; Andueza A; Kumar S; Kang DW; Zhang J; Tamargo I; Villa-Roel N; Baek KI; Lee H; An Y; Zhang L; Tate EW; Bagchi P; Pohl J; Mosnier LO; Diamandis EP; Mihara K; Hollenberg MD; Dai Z; Jo H
Elife; 2022 Jan; 11():. PubMed ID: 35014606
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of KLK5-8 in endometrial cancer.
Lei S; Zhang Q; Yin F; He X; Wang J
Am J Transl Res; 2019; 11(7):4180-4191. PubMed ID: 31396327
[TBL] [Abstract][Full Text] [Related]
8. Myometrial progesterone hyper-responsiveness associated with increased risk of human uterine fibroids.
Omar M; Laknaur A; Al-Hendy A; Yang Q
BMC Womens Health; 2019 Jul; 19(1):92. PubMed ID: 31288815
[TBL] [Abstract][Full Text] [Related]
9. Kallikrein 12 Regulates Innate Resistance of Murine Macrophages against
Sabir N; Hussain T; Liao Y; Wang J; Song Y; Shahid M; Cheng G; Mangi MH; Yao J; Yang L; Zhao D; Zhou X
Cells; 2019 May; 8(5):. PubMed ID: 31060300
[No Abstract] [Full Text] [Related]
10. Selection for female traits of high fertility affects male reproductive performance and alters the testicular transcriptional profile.
Michaelis M; Sobczak A; Koczan D; Langhammer M; Reinsch N; Schoen J; Weitzel JM
BMC Genomics; 2017 Nov; 18(1):889. PubMed ID: 29157197
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes.
Stefanini AC; da Cunha BR; Henrique T; Tajara EH
Dis Markers; 2015; 2015():946572. PubMed ID: 26783378
[TBL] [Abstract][Full Text] [Related]
12. Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors.
Kostova MB; Rosen DM; Chen Y; Mease RC; Denmeade SR
J Med Chem; 2013 Jun; 56(11):4224-35. PubMed ID: 23692593
[TBL] [Abstract][Full Text] [Related]
13. Tissue kallikrein activation of the epithelial Na channel.
Patel AB; Chao J; Palmer LG
Am J Physiol Renal Physiol; 2012 Aug; 303(4):F540-50. PubMed ID: 22622459
[TBL] [Abstract][Full Text] [Related]
14. Trypsin-like proteolytic contamination of commercially available psa purified from human seminal fluid.
Manning ML; Kostova M; Williams SA; Denmeade SR
Prostate; 2012 Aug; 72(11):1233-8. PubMed ID: 22213008
[TBL] [Abstract][Full Text] [Related]
15. Protein-binding microarray analysis of tumor suppressor AP2α target gene specificity.
Kerschgens J; Renaud S; Schütz F; Grasso L; Egener-Kuhn T; Delaloye JF; Lehr HA; Vogel H; Mermod N
PLoS One; 2011; 6(8):e22895. PubMed ID: 21876733
[TBL] [Abstract][Full Text] [Related]
16. A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.
Batra J; Nagle CM; O'Mara T; Higgins M; Dong Y; Tan OL; Lose F; Skeie LM; Srinivasan S; Bolton KL; Song H; Ramus SJ; Gayther SA; Pharoah PD; Kedda MA; Spurdle AB; Clements JA
BMC Cancer; 2011 Apr; 11():119. PubMed ID: 21457553
[TBL] [Abstract][Full Text] [Related]
17. Development of a brain metastatic canine prostate cancer cell line.
Thudi NK; Shu ST; Martin CK; Lanigan LG; Nadella MV; Van Bokhoven A; Werbeck JL; Simmons JK; Murahari S; Kisseberth WC; Breen M; Williams C; Chen CS; McCauley LK; Keller ET; Rosol TJ
Prostate; 2011 Sep; 71(12):1251-63. PubMed ID: 21321976
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer.
Angelopoulou K; Karagiannis GS
Mamm Genome; 2010 Oct; 21(9-10):516-24. PubMed ID: 20853168
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer.
LeBeau AM; Kostova M; Craik CS; Denmeade SR
Biol Chem; 2010 Apr; 391(4):333-43. PubMed ID: 20180648
[TBL] [Abstract][Full Text] [Related]
20. Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis.
Blaber M; Yoon H; Juliano MA; Scarisbrick IA; Blaber SI
Biol Chem; 2010 Apr; 391(4):311-20. PubMed ID: 20128685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
